We are live on
!
Find out more
WA
WestEnd Advisors Portfolio holdings
AUM
$4.14B
1-Year Est. Return
15.99%
This Fund
S&P 500
This Quarter
Est. Return
+1.26%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$963M
AUM Growth
-$99M
(-9.3%)
Cap. Flow
-$111M
Cap. Flow
% of AUM
-11.58%
Top 10 Holdings %
Top 10 Hldgs %
40.11%
Holding
51
New
2
Increased
19
Reduced
24
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$37M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$7.9M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$7.85M |
| 4 |
Kraft Heinz
KHC
|
+$5M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$4.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$38.2M |
| 2 |
Mastercard
MA
|
+$18.3M |
| 3 |
TJX Companies
TJX
|
+$16.5M |
| 4 |
Microsoft
MSFT
|
+$14.9M |
| 5 |
UnitedHealth
UNH
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.53% |
| 2 | Financials | 19.02% |
| 3 | Consumer Staples | 12.18% |
| 4 | Communication Services | 11.62% |
| 5 | Technology | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Kraft Heinz
KHC
$30.7B
| $40.2M | 4.17% |
639,378
+84,191
| +15% | +$5M |
|
2
Bristol-Myers Squibb
BMY
$124B
| $39.5M | 4.1% |
713,517
+34,634
| +5% | +$1.87M |
|
|
3
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
| $39M | 4.06% |
753,197
+91,819
| +14% | +$4.98M |
|
4
Walmart Inc
WMT
$909B
| $38.7M | 4.02% |
1,356,363
+47,793
| +4% | +$1.36M |
|
5
Walt Disney
DIS
$170B
| $38.4M | 3.99% |
366,302
-59,414
| -14% | -$6.08M |
|
|
6
Procter & Gamble
PG
$349B
| $38.4M | 3.99% |
+491,624
| New | +$37M |
|
|
7
TJX Companies
TJX
$171B
| $38.2M | 3.97% |
803,428
-375,352
| -32% | -$16.5M |
|
8
Alphabet (Google) Class A
GOOGL
$4.23T
| $38M | 3.95% |
672,660
-183,460
| -21% | -$9.98M |
|
9
PayPal
PYPL
$49.9B
| $37.9M | 3.94% |
454,901
-148,486
| -25% | -$11.8M |
|
|
10
Mastercard
MA
$480B
| $37.8M | 3.93% |
192,321
-97,274
| -34% | -$18.3M |
|
11
Gilead Sciences
GILD
$167B
| $37.7M | 3.92% |
532,852
-16,906
| -3% | -$1.19M |
|
12
Medtronic
MDT
$106B
| $37.7M | 3.91% |
439,959
-101,255
| -19% | -$8.46M |
|
|
13
Microsoft
MSFT
$2.93T
| $37.3M | 3.87% |
378,124
-153,874
| -29% | -$14.9M |
|
|
14
UnitedHealth
UNH
$387B
| $37.2M | 3.86% |
151,597
-52,950
| -26% | -$12.7M |
|
15
Apple
AAPL
$4.9T
| $37.1M | 3.85% |
801,756
-276,868
| -26% | -$12.6M |
|
16
Biogen
BIIB
$30.4B
| $35.9M | 3.73% |
123,613
-9,174
| -7% | -$2.58M |
|
17
JPMorgan Chase
JPM
$907B
| $35.9M | 3.73% |
344,276
-81,008
| -19% | -$8.89M |
|
18
Goldman Sachs
GS
$314B
| $35.8M | 3.72% |
162,246
-13,504
| -8% | -$3.22M |
|
19
Bank of America
BAC
$430B
| $35.8M | 3.71% |
1,268,199
-277,645
| -18% | -$8.28M |
|
20
AT&T
T
$152B
| $35.5M | 3.69% |
1,462,956
-143,870
| -9% | -$3.61M |
|
21
Starbucks
SBUX
$120B
| $33M | 3.43% |
674,973
-101,997
| -13% | -$5.79M |
|
22
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
| $31.3M | 3.25% |
374,563
-28,652
| -7% | -$2.37M |
|
23
State Street Technology Select Sector SPDR ETF
XLK
$114B
| $30.9M | 3.21% |
888,708
+57,254
| +7% | +$1.96M |
|
24
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.3B
| $25.2M | 2.62% |
461,818
+27,954
| +6% | +$1.48M |
|
|
25
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
| $19.1M | 1.98% |
370,274
+154,630
| +72% | +$7.85M |
|
Similar funds
GCM
SP
ZP
BOK
SHCM
AP
CG
BT
WestEnd Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, WestEnd Advisors held 51 positions worth $963M, down 9.3% from $1.06B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
WestEnd Advisors withdrew a net $111M in Q2 2018, reducing 24 holdings. Its largest reduction was Allergan plc, cutting an estimated $38.2M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, WestEnd Advisors opened a new position in Procter & Gamble worth $38.4M.
- WestEnd Advisors's largest Q2 2018 buy was Procter & Gamble: 491,624 shares worth $38.4M.
- WestEnd Advisors added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2018, an estimated $7.9M increase.
- WestEnd Advisors's biggest Q2 2018 reduction was Allergan plc, cutting an estimated $38.2M.
- WestEnd Advisors's ten largest holdings make up 40% of its $963M portfolio in Q2 2018.
- WestEnd Advisors opened 2 new positions and closed 0 in Q2 2018.
- WestEnd Advisors's portfolio value fell 9.3% quarter-over-quarter to $963M.
Based on WestEnd Advisors's 13F filing for Q2 2018, filed 26 Jul 2018.